CollPlant Competitors and Similar CompaniesClear all
CollPlant's competitors and similar companies include Plus Therapeutics, Pharmanutra, Delcath Systems and VaxCare.
 CollPlant CollPlant Biotechnologies is a medicine company that develops technologies and products for tissue regeneration and organ manufacturing. |  Plus Therapeutics Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases. |  Pharmanutra Pharmanutra, a pharmaceutical company, engages in the research, design, development, and marketing of nutraceutical supplements and medical devices. |  Delcath Systems Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology. | ||
Founding Date | Founding Date 1981 | Founding Date 1996 | Founding Date 2003 | Founding Date 1988 | Founding Date 2007 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Rehovot, IL HQ | Locations Austin, US HQ San Antonio, US | Locations Pisa, IT HQ Pisa, IT | Locations New York, US HQ Galway, IE Queensbury, US | Locations Orlando, US HQ |
Employees | Employees 5724% decrease | Employees 1721% increase | Employees 118 | Employees 437% decrease | Employees 3804% increase |
Valuation ($) | Valuation ($) 44.9 m | Valuation ($) 8 m | Valuation ($) 589.3 m | Valuation ($) 294.6 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $2.4m (FY, 2025) | Revenue (est.) $5.2m (FY, 2025) | Revenue (est.) €115.5m (FY, 2024) | Revenue (est.) $85.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $835k (FY, 2025) | Cost of goods N/A | Cost of goods €6.4m (FY, 2024) | Cost of goods $11.8m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $1.5m (FY, 2025) | Gross profit N/A | Gross profit €110.5m (FY, 2024) | Gross profit $73.4m (FY, 2025) | Gross profit N/A |
Net income | Net income ($11.5m) (FY, 2025) | Net income ($22.4m) (FY, 2025) | Net income €16.6m (FY, 2024) | Net income $2.7m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 71.9m | Total funding raised N/A | Total funding raised $ 42m | Total funding raised $ 1.5m |
For sources of this data, please see the company profile
View Company Profiles
Plus Therapeutics
HQ
Austin, US
Employees
17↑ 21% increase
Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases.
View companyPharmanutra
HQ
Pisa, IT
Employees
118
Pharmanutra, a pharmaceutical company, engages in the research, design, development, and marketing of nutraceutical supplements and medical devices.
View companyDelcath Systems
HQ
New York, US
Employees
43↓ 7% decrease
Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.
View company
VaxCare
HQ
Orlando, US
Employees
380↑ 4% increase
VaxCare is a company that builds technology to manage vaccination workflow.
View company